Anatara Lifesciences : Application for quotation of securities - ANR

About this update from Anatara Lifesciences Ltd

Application for quotation of +securities Announcement Summary For personal use only Entity name ANATARA LIFESCIENCES LTD Announcement Type New announcement Date of this announcement Friday December 10, 2021 The +securities to be quoted are: +Securities issued, transferred or re-classified as a result of options being exercised or other +convertible securities being converted Total number of +securities to be quoted ASX +security Number of +securities to code Security description be quoted Issue date ANR ORDINARY FULLY PAID 38,624 09/12/2021 Refer to next page for full details of the announcement Application for quotation of +securities 1 / 6 Application for quotation of +securities Part 1 - Entity and announcement details For personal use only 1.1 Name of entity ANATARA LIFESCIENCES LTD We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules. 1.2 Registered number type Registration number ABN 41145239872 1.3 ASX issuer code ANR The announcement is New announcement Date of this announcement 10/12/2021 Application for quotation of +securities 2 / 6 Application for quotation of +securities Part 2 - Type of Issue For personal use only 2.1 The +securities to be quoted are: +Securities issued, transferred or re-classified as a result of options being exercised or other +convertible securities being converted 2.2 The +securities to be quoted are: Additional +securities in a class that is already quoted on ASX ("existing class") Application for quotation of +securities 3 / 6 Application for quotation of +securities Part 3B - number and type of +securities to be quoted (existing class) where issue has not previously been notified to ASX in an Appendix 3B Existing +securities converting into additional +securities in an existing class FROM (Existing Class) ASX +security code and description ANRAK : PERFORMANCE RIGHTS TO (Existing Class) ASX +security code and description ANR : ORDINARY FULLY PAID Please state the number of options that were exercised or other +convertible securities that were converted 38,624 The first date the options were exercised or other +convertible securities were converted 9/12/2021 The last date the options were exercised or other +convertible securities were converted 9/12/2021 For personal use only Is this all of the options or other +convertible securities on issue of that type (ie have all of those options now been exercised or have all of those convertible securities now been converted)? Yes The right of the holder of the options or other +convertible securities to receive the +underlying securities is being satisfied by: An issue of new +securities The underlying securities being received by the holder are: Intended to be, but are not yet, quoted by ASX Were the options being exercised or other +convertible securities being converted issued under an +employee incentive scheme? Yes Are any of the options being exercised or other +convertible securities being converted held by +key management personnel (KMP) or an +associate? No Issue date 9/12/2021 Will the +securities to be quoted rank equally in all respects from their issue date with the existing issued +securities in that class? Yes Application for quotation of +securities 4 / 6 Application for quotation of +securities Issue details For personal use only Number of +securities to be quoted 38,624 Are the +securities being issued for a cash consideration? No Please describe the consideration being provided for the +securities Performance Rights were issued at Nil cost Please provide an estimate (in AUD) of the value of the consideration being provided per +security for the +securities to be quoted 0.000000 Any other information the entity wishes to provide about the +securities to be quoted Application for quotation of +securities 5 / 6 This is an excerpt of the original content. To continue reading it, access the original document here .

View stock analysis, news, and events for Anatara Lifesciences Ltd